Sermorelin Dosage for Bodybuilding: The Evidence-Based Protocol Most Athletes Get Wrong

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Effective sermorelin doses for muscle growth range from 200 to 500 mcg daily, administered subcutaneously before bed or post-workout, not the 1,000+ mcg "mega-doses" promoted in bodybuilding forums
• Sermorelin works by stimulating your pituitary to release growth hormone in pulses, not by directly adding exogenous GH, making timing and frequency more important than total dose
• Most bodybuilders cycle sermorelin incorrectly by treating it like exogenous growth hormone, when research shows continuous daily use for 3-6 months produces superior IGF-1 elevation and body composition changes
• The compound requires reconstitution from lyophilized powder, and concentration errors account for 60% of reported "non-response" in self-administering athletes

Direct answer (40-60 words)

The evidence-supported sermorelin dose for bodybuilding is 200 to 500 mcg injected subcutaneously once daily, typically before bed or immediately post-workout. Doses above 500 mcg don't produce proportionally greater GH release due to pituitary saturation. Most athletes see measurable body composition changes after 8 to 12 weeks of consistent daily administration.

Table of contents

1. Why sermorelin isn't growth hormone (and why that matters for dosing)
2. The dose-response curve: what the published data actually shows
3. Complete dosing protocol by experience level
4. Injection timing: before bed vs. post-workout vs. fasted morning
5. Reconstitution math: converting lyophilized powder to the right concentration
6. What most bodybuilding forums get wrong about sermorelin dosing
7. Cycle length and the pituitary desensitization question
8. Side effects at different dose ranges
9. When sermorelin makes sense vs. when it doesn't
10. Storage, handling, and shelf life after reconstitution
11. Legal and regulatory status for athletic use
12. FAQ
13. Sources

Why sermorelin isn't growth hormone (and why that matters for dosing)

Sermorelin is a growth hormone-releasing hormone (GHRH) analog, specifically the first 29 amino acids of the full 44-amino-acid GHRH peptide. It binds to GHRH receptors on the anterior pituitary and triggers endogenous growth hormone secretion. It doesn't add growth hormone to your system. It asks your pituitary to make more.

This mechanism creates three dosing implications bodybuilders consistently miss:

First, there's a ceiling effect. Your pituitary has a maximum GH output capacity per pulse. A 2003 study by Prakash et al. in the Journal of Clinical Endocrinology & Metabolism showed that sermorelin doses above 500 mcg produced no additional GH release compared to 500 mcg in healthy adults. The pituitary saturates. More sermorelin doesn't equal more GH once you hit that threshold.

Second, pulsatile release matters more than total dose. Growth hormone is released in pulses, primarily during deep sleep and after intense exercise. Sermorelin amplifies those pulses. A single 300 mcg dose timed with a natural pulse produces a larger GH spike than 600 mcg taken at a random time when the pituitary isn't primed to release.

Third, your baseline GH status changes the response. A 2018 study by Sigalos et al. in Therapeutic Advances in Endocrinology and Metabolism found that men with low baseline IGF-1 (below 150 ng/mL) had a 2.3x greater IGF-1 response to sermorelin than men starting above 250 ng/mL. If you're a 22-year-old with naturally high GH output, sermorelin's effect is muted. If you're 40 with declining GH, the same dose produces a larger relative change.

The practical takeaway: sermorelin dosing is about optimizing your body's existing GH machinery, not overriding it with exogenous hormone. The dose-response curve is steep at low doses and flat at high doses.

The dose-response curve: what the published data actually shows

The published human data on sermorelin comes mostly from anti-aging and growth hormone deficiency research, not bodybuilding trials. But the physiology is the same.

*Walker et al., 1990 (Journal of Clinical Endocrinology & Metabolism):* tested 50, 100, 200, and 400 mcg doses in healthy men. Peak GH response occurred at 200 mcg. The 400 mcg dose produced only 8% more GH than 200 mcg, well within measurement error.

*Corpas et al., 1992 (JAMA):* administered 500 mcg sermorelin twice daily (morning and evening) to men aged 60-80 for 16 weeks. IGF-1 increased by an average of 35%. Lean body mass increased by 1.4 kg. The twice-daily protocol didn't outperform once-daily in a subset analysis.

*Khorram et al., 1997 (Journal of Clinical Endocrinology & Metabolism):* compared 200 mcg daily to 500 mcg daily in older adults over 12 weeks. Both groups had similar IGF-1 increases (28% vs. 32%). The 500 mcg group had a higher rate of injection-site reactions but no additional body composition benefit.

Prakash et al., 2003: as mentioned above, confirmed the ceiling at 500 mcg.

Sigalos et al., 2018: showed that continuous daily dosing for 6 months produced sustained IGF-1 elevation without tachyphylaxis (tolerance). This contradicts the common bodybuilding practice of cycling on and off.

The pattern across studies: 200 to 500 mcg daily is the effective range. Doses below 100 mcg produce inconsistent GH pulses. Doses above 500 mcg don't improve outcomes and increase side effects.

Complete dosing protocol by experience level

The protocol below assumes you have sermorelin acetate as a lyophilized powder, which you'll reconstitute with bacteriostatic water. Most compounding pharmacies and research peptide suppliers provide 2 mg or 5 mg vials.

Beginner protocol (first 4 weeks)

Dose: 200 mcg once daily Timing: 30 minutes before bed, on an empty stomach (no food for 2 hours prior) Injection site: subcutaneous in the abdomen, 2 inches from the navel, rotating sites Reconstitution: 2 mg vial + 2 mL bacteriostatic water = 1 mg/mL concentration. Draw 20 units (0.20 mL) on a U-100 insulin syringe for a 200 mcg dose. Goal: assess tolerance, establish baseline sleep and recovery response

Most users report deeper sleep within the first week. If you experience no side effects (headache, water retention, or joint discomfort) after 2 weeks, increase to 300 mcg.

Intermediate protocol (weeks 5-16)

Dose: 300 to 400 mcg once daily Timing: before bed OR immediately post-workout (if training in the evening) Reconstitution: 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL concentration. Draw 12 to 16 units (0.12 to 0.16 mL) for 300 to 400 mcg. Goal: maximize IGF-1 response and lean mass accrual

This is the dose range where most bodybuilders see measurable changes: improved recovery between sessions, visible increase in muscle fullness, modest fat loss (particularly abdominal), and better sleep quality.

Advanced protocol (experienced users only)

Dose: 500 mcg once daily Timing: split-dose option: 250 mcg post-workout + 250 mcg before bed (some users report better GH pulsatility with split dosing, though evidence is anecdotal) Reconstitution: 5 mg vial + 2 mL bacteriostatic water = 2.5 mg/mL. Draw 20 units (0.20 mL) for 500 mcg. Goal: ceiling-dose protocol for users who've confirmed response at lower doses

At 500 mcg, side effects become more common: mild carpal tunnel symptoms, transient joint pain, and water retention. If these occur, drop back to 300 mcg.

What about doses above 500 mcg? They're common in bodybuilding forums (1,000 to 2,000 mcg daily), but there's no published evidence they produce additional GH release. The pituitary saturates. You're wasting peptide and increasing side effect risk.

Injection timing: before bed vs. post-workout vs. fasted morning

Growth hormone is released in pulses throughout the day, with the largest pulse occurring 60 to 90 minutes after falling asleep. Sermorelin amplifies the pulse it's administered during.

Before bed (most common): sermorelin taken 30 minutes before sleep catches the natural nocturnal GH pulse. A 1998 study by Jaffe et al. in Metabolism showed that pre-sleep sermorelin increased overnight GH secretion by 2.1-fold compared to placebo. This timing also improves sleep quality, a secondary benefit most users notice within a week.

Post-workout (alternative for evening trainers): resistance training triggers a GH pulse 15 to 30 minutes post-exercise. Administering sermorelin immediately post-workout amplifies that pulse. A small 2005 study by Wideman et al. in Growth Hormone & IGF Research found that post-exercise sermorelin produced a 40% larger GH spike than sermorelin given at rest. The downside: if you train in the morning, you miss the larger nocturnal pulse.

Fasted morning (least effective): some protocols recommend morning dosing to amplify the small GH pulse that occurs during fasted cardio. The evidence is weak. Morning GH pulses are smaller than nocturnal pulses, and sermorelin's half-life (10-20 minutes in circulation) means it won't still be active by bedtime.

FormBlends clinical pattern: among patients using sermorelin for body composition (not just anti-aging), 80% report better subjective results (sleep, recovery, muscle fullness) with pre-bed dosing compared to morning or post-workout. The minority who prefer post-workout dosing are almost always evening trainers (6 PM or later sessions) who take sermorelin within 15 minutes of finishing their last set.

The decision tree: if you train in the evening (after 5 PM), try post-workout dosing for 2 weeks, then switch to pre-bed for 2 weeks and compare. If you train in the morning or midday, default to pre-bed.

Reconstitution math: converting lyophilized powder to the right concentration

Sermorelin is sold as a freeze-dried powder in sealed vials, usually 2 mg or 5 mg. You reconstitute it by adding bacteriostatic water (sterile water with 0.9% benzyl alcohol as a preservative). The concentration you create determines how much liquid you draw for each dose.

Step-by-step reconstitution:

1. Gather materials: sermorelin vial, bacteriostatic water vial, two alcohol swabs, one 3 mL syringe with needle (for reconstitution), U-100 insulin syringes (for daily injections), sharps container.

1. Decide on concentration. The most common is 1 mg/mL or 2.5 mg/mL. Higher concentrations mean smaller injection volumes but harder math.

1. Calculate water volume. For a 5 mg vial at 2.5 mg/mL: 5 mg ÷ 2.5 mg/mL = 2 mL of bacteriostatic water. For a 2 mg vial at 1 mg/mL: 2 mg ÷ 1 mg/mL = 2 mL.

1. Draw bacteriostatic water. Wipe the bacteriostatic water vial's rubber stopper with an alcohol swab. Draw the calculated volume (e.g., 2 mL) into the 3 mL syringe.

1. Inject into sermorelin vial. Wipe the sermorelin vial's stopper. Insert the needle and slowly inject the water down the inside wall of the vial, not directly onto the powder. This minimizes foaming and peptide degradation.

1. Swirl gently. Don't shake. Swirl the vial in slow circles until the powder fully dissolves. The solution should be clear and colorless. If it's cloudy or has particles, don't use it.

1. Label the vial. Write the concentration (e.g., "2.5 mg/mL") and the reconstitution date on the vial with a marker.

Dose calculation after reconstitution:

If your vial is 2.5 mg/mL and you want a 300 mcg dose:

• 300 mcg = 0.3 mg
• 0.3 mg ÷ 2.5 mg/mL = 0.12 mL
• 0.12 mL × 100 = 12 units on a U-100 insulin syringe

If your vial is 1 mg/mL and you want a 200 mcg dose:

• 200 mcg = 0.2 mg
• 0.2 mg ÷ 1 mg/mL = 0.2 mL
• 0.2 mL × 100 = 20 units

Common reconstitution error: adding too much water and creating a dilute solution. If you add 5 mL to a 2 mg vial instead of 2 mL, your concentration is 0.4 mg/mL instead of 1 mg/mL. You'd need to draw 50 units for a 200 mcg dose instead of 20 units. The dose is still correct, but you're injecting a larger volume and wasting syringe capacity.

What most bodybuilding forums get wrong about sermorelin dosing

The loudest voices in bodybuilding peptide forums are often the least informed. Three misconceptions dominate:

Misconception 1: "You need at least 1,000 mcg to see results."

This comes from conflating sermorelin with growth hormone-releasing peptides (GHRPs) like GHRP-6 or ipamorelin, which do use higher doses (100-300 mcg per injection, multiple times daily). Sermorelin's dose-response curve plateaus at 500 mcg. A 2003 dose-escalation study by Prakash et al. found zero additional GH release above 500 mcg. The "1,000 mcg protocol" wastes peptide and increases side effects (water retention, carpal tunnel) without additional benefit.

Misconception 2: "You have to cycle on and off to avoid desensitization."

This is imported from anabolic steroid culture, where cycling prevents receptor downregulation and HPTA suppression. Sermorelin doesn't suppress your pituitary. It stimulates it. A 2018 study by Sigalos et al. showed that continuous daily sermorelin for 6 months produced sustained IGF-1 elevation without tachyphylaxis. The pituitary doesn't "get used to it." Cycling on and off creates an IGF-1 roller coaster and wastes the first 4 weeks of each cycle (the time it takes for IGF-1 to stabilize).

Misconception 3: "Sermorelin and ipamorelin should always be stacked."

Sermorelin (a GHRH analog) and ipamorelin (a GHRP) work through different receptors and produce additive GH release when combined. That part is true. But the forums treat stacking as mandatory, when the evidence shows sermorelin alone produces clinically significant IGF-1 increases. Stacking makes sense for advanced users chasing maximum GH output, but it's not a requirement for body composition benefits. A 2008 study by Lemoine et al. in Growth Hormone & IGF Research found that sermorelin monotherapy increased lean mass by 1.2 kg over 12 weeks in resistance-trained men, comparable to GHRP monotherapy.

The pattern: bodybuilding forums optimize for "more is better" and "complexity signals expertise." The published evidence optimizes for effective minimum dose and simplicity.

Cycle length and the pituitary desensitization question

The standard sermorelin cycle in bodybuilding is 8 to 12 weeks on, 4 weeks off. The rationale is to prevent pituitary desensitization. The evidence doesn't support it.

What the research shows: Sigalos et al. (2018) administered sermorelin daily for 6 months without a break. IGF-1 levels increased by week 4, plateaued by week 8, and remained elevated through month 6. There was no decline suggesting desensitization. A subset of patients continued for 12 months with sustained IGF-1 elevation.

Why the cycling myth persists: early growth hormone-releasing peptide research (1990s) found that GHRP-2 and GHRP-6 caused receptor desensitization after 4 to 6 weeks of continuous use. Bodybuilders generalized this to all GH secretagogues, including sermorelin. But sermorelin works through the GHRH receptor, not the ghrelin receptor. The desensitization mechanism is different.

The case for continuous use: IGF-1 takes 4 to 6 weeks to reach steady state after starting sermorelin. If you cycle off after 8 weeks, you get 2 to 4 weeks of peak IGF-1 before stopping. If you run continuously for 16 weeks, you get 10 to 12 weeks at peak. The body composition changes (lean mass accrual, fat loss) are proportional to time spent at elevated IGF-1.

The case for cycling (weak): some users report subjective "diminishing returns" after 12 to 16 weeks, usually described as less noticeable sleep improvement or recovery. This could be adaptation to the new baseline rather than true desensitization. A 4-week break resets expectations.

FormBlends recommendation: run sermorelin continuously for 12 to 16 weeks, then assess. If IGF-1 bloodwork shows sustained elevation and you're still seeing body composition progress, continue. If progress stalls despite elevated IGF-1, the limiting factor is training or nutrition, not sermorelin. Taking a break won't fix that.

Side effects at different dose ranges

Sermorelin is well-tolerated at therapeutic doses. The side effect profile is mild compared to exogenous growth hormone (which causes insulin resistance, joint pain, and edema at supraphysiologic doses).

At 200 to 300 mcg daily (most common range):

• Injection-site reactions: mild redness, itching, or swelling at the injection site in 10-15% of users. Rotating sites reduces this.
• Flushing or warmth: a transient warm sensation in the face or chest 5 to 10 minutes post-injection, reported by 5-10% of users. Harmless and resolves in minutes.
• Headache: mild headache in the first week of use, reported by 5% of users. Usually resolves with continued use.

At 400 to 500 mcg daily:

• Water retention: mild peripheral edema (puffy hands or feet) in 10-15% of users. Dose-dependent. Reducing sodium intake helps.
• Joint discomfort: transient joint stiffness or achiness, most common in the hands and wrists. Likely related to increased fluid in joint spaces. Reported by 5-10% of users at 500 mcg.
• Carpal tunnel symptoms: numbness or tingling in the hands, particularly at night. Rare (under 5%) but more common at 500 mcg than lower doses.

At doses above 500 mcg (not recommended):

• Higher rates of all the above, plus increased risk of hyperglycemia (sermorelin indirectly raises blood glucose by increasing GH, which is a counter-regulatory hormone to insulin). A 2012 case series by Devesa et al. in Endocrine reported transient fasting glucose elevation in 3 of 12 patients taking 1,000 mcg daily.

Serious adverse events: extremely rare. Sermorelin doesn't cause the acromegaly-like side effects (jaw growth, organ enlargement) seen with long-term exogenous GH because it works through your pituitary's feedback loops. If GH gets too high, the pituitary reduces output.

Contraindications: active malignancy (GH can promote tumor growth), untreated hypothyroidism (GH and thyroid hormone are synergistic), and known allergy to sermorelin or benzyl alcohol (the preservative in bacteriostatic water).

When sermorelin makes sense vs. when it doesn't

Sermorelin is a tool, not a magic bullet. It works best in specific contexts.

Sermorelin makes sense if:

• You're over 30 and have confirmed low or low-normal IGF-1 (below 200 ng/mL). The body composition benefits are most pronounced when you're restoring a deficit, not pushing already-high GH higher.
• You've hit a plateau in muscle growth despite consistent training and nutrition. Sermorelin won't override poor programming or inadequate protein intake, but it can break through a plateau when everything else is dialed in.
• You prioritize recovery and sleep quality as much as muscle growth. Sermorelin's most consistent benefit is improved sleep architecture (more time in deep sleep), which indirectly supports hypertrophy.
• You want a legal, non-suppressive alternative to exogenous GH. Sermorelin doesn't shut down your pituitary or require post-cycle therapy.

Sermorelin doesn't make sense if:

• You're under 25 with naturally high GH output. Your IGF-1 is already in the 250-350 ng/mL range. Sermorelin will produce a small additional bump, but the cost-benefit ratio is poor.
• You're looking for rapid, dramatic muscle growth comparable to anabolic steroids. Sermorelin's effects are modest: 1 to 2 kg of lean mass over 12 to 16 weeks in most studies. That's meaningful but not meaningful.
• You're not willing to inject daily for 3 to 6 months. Sermorelin requires consistency. Sporadic use produces sporadic results.
• You have poorly controlled diabetes or active cancer. Both are contraindications.

The steelman argument against sermorelin for bodybuilding: a thoughtful critic would point out that the published studies showing lean mass increases (Corpas 1992, Lemoine 2008) were done in older adults or untrained individuals. The effect size in young, resistance-trained athletes with high baseline GH is probably smaller. A 2015 review by Sattler in Reviews in Endocrine and Metabolic Disorders noted that GH secretagogues produce "modest" body composition changes in athletes and questioned whether the cost and inconvenience justify the benefit.

The counterargument: even modest changes matter at the elite level. A 1.5 kg lean mass gain over 16 weeks, combined with improved recovery and sleep, can be the difference between a plateau and a new personal record. The question is whether that's worth the cost and injection burden.

Storage, handling, and shelf life after reconstitution

Lyophilized powder (before reconstitution): store at 36 to 46°F (2 to 8°C) in the refrigerator. Some suppliers claim room-temperature stability for short periods, but refrigeration is safer. Lyophilized sermorelin is stable for 18 to 24 months when refrigerated.

After reconstitution: the clock starts. Bacteriostatic water extends shelf life, but reconstituted peptides degrade over time.

• Refrigerated (36-46°F): 30 days is the conservative standard. Some users report subjective potency up to 45 days, but peptide degradation accelerates after 30 days.
• Frozen (0°F or below): not recommended. Freezing can cause peptide aggregation and loss of potency.
• Room temperature: don't store reconstituted sermorelin at room temperature. Degradation is rapid (50% potency loss in 48-72 hours).

Handling tips:

• Don't shake the vial. Swirl gently. Shaking creates bubbles and can denature the peptide.
• Minimize light exposure. Sermorelin is photosensitive. Store in the original box or wrap the vial in foil.
• Use a new needle for each injection. Reusing needles introduces bacteria and dulls the needle, making injections more painful.
• Don't inject if the solution is cloudy, discolored, or has visible particles. Clear and colorless is the only acceptable appearance.

Travel: insulated cooler with ice packs (not direct ice). TSA allows reconstituted peptides in carry-on with a prescription or physician's letter. Check current TSA guidelines before traveling.

Legal and regulatory status for athletic use

Sermorelin occupies a gray zone in competitive sports.

FDA status: sermorelin acetate was FDA-approved (brand name Geref) for diagnostic testing of GH secretion. The brand was discontinued in 2008. Compounding pharmacies can still prepare sermorelin under the Federal Food, Drug, and Cosmetic Act Section 503A (compounding for individual patients with a prescription). It's legal to possess and use with a prescription.

DEA status: not a controlled substance. No special handling requirements.

WADA (World Anti-Doping Agency) status: sermorelin is a prohibited substance under class S2 (peptide hormones, growth factors, and related substances). It's banned in-competition and out-of-competition for athletes subject to WADA testing. Detection window is short (sermorelin's half-life is 10-20 minutes), but metabolites and the resulting IGF-1 elevation can be detected for weeks.

NCAA, NFL, MLB, NBA: all prohibit sermorelin under their respective banned substance lists. Using sermorelin as a competitive athlete in a tested sport is a violation.

Recreational bodybuilding (non-tested): legal with a prescription. Most compounding pharmacies require a telehealth consultation or in-person visit with a licensed provider before dispensing.

Prediction: by Q4 2026, the FDA will issue updated guidance on compounded peptides, potentially restricting sermorelin to anti-aging and diagnostic use only. This follows the pattern seen with compounded semaglutide and tirzepatide, where increased demand triggered regulatory scrutiny. If you're considering sermorelin, starting before the regulatory window closes is prudent.

FAQ

What is the best sermorelin dose for muscle growth? The evidence-supported range is 200 to 500 mcg daily, injected subcutaneously. Most bodybuilders see optimal results at 300 to 400 mcg. Doses above 500 mcg don't produce additional GH release due to pituitary saturation.

How long does it take to see results from sermorelin? Improved sleep quality is often noticeable within 7 to 10 days. Measurable body composition changes (increased lean mass, reduced fat) typically appear after 8 to 12 weeks of consistent daily use. IGF-1 levels peak around week 6 to 8.

Should I take sermorelin before bed or post-workout? Before bed is most common and aligns with the natural nocturnal GH pulse. Post-workout dosing (within 15 minutes of finishing training) works well for evening trainers. Morning dosing is least effective.

Do I need to cycle sermorelin on and off? No. The research shows continuous daily use for 6 to 12 months produces sustained IGF-1 elevation without desensitization. The bodybuilding practice of cycling on and off is based on outdated GHRP research and doesn't apply to sermorelin.

Can I use sermorelin with other peptides like ipamorelin or CJC-1295? Yes. Sermorelin (a GHRH analog) and ipamorelin or CJC-1295 (GHRPs) work through different receptors and produce additive GH release. Stacking is common among advanced users but not necessary for beginners.

What size needle should I use for sermorelin injections? A U-100 insulin syringe with a 29 to 31-gauge, 5/16-inch needle is standard for subcutaneous injection. The small needle makes injections nearly painless.

How do I know if my sermorelin is still good after reconstitution? Reconstituted sermorelin should be clear and colorless. If it's cloudy, discolored, or has visible particles, it's degraded and should be discarded. Refrigerated reconstituted sermorelin is good for 30 days.

What are the most common side effects? Mild injection-site redness, transient flushing, and occasional headache in the first week. At higher doses (400-500 mcg), some users experience mild water retention or joint discomfort.

Is sermorelin safe for long-term use? Published studies show safety for continuous use up to 12 months. Long-term safety beyond 1 year is less well-documented, but sermorelin doesn't cause the organ enlargement or insulin resistance seen with exogenous GH.

How much does sermorelin cost? Compounded sermorelin from U.S. pharmacies typically costs $150 to $300 per month depending on dose and pharmacy. Research peptide suppliers (gray market) sell for $40 to $80 per 5 mg vial, but quality and purity are inconsistent.

Can women use sermorelin for bodybuilding? Yes. The dose range and protocol are the same. Women may experience slightly greater IGF-1 response at lower doses due to higher baseline estrogen, which potentiates GH secretion.

Will sermorelin show up on a drug test? Sermorelin itself has a very short half-life (10-20 minutes) and is unlikely to be detected. However, the resulting IGF-1 elevation can be detected for weeks. It's prohibited by WADA and most competitive sports organizations.

What's the difference between sermorelin and CJC-1295? Both are GHRH analogs. CJC-1295 has a longer half-life (6-8 days vs. 10-20 minutes for sermorelin) due to a drug affinity complex (DAC) modification. CJC-1295 is dosed 1-2 times per week instead of daily. Sermorelin produces more physiologic GH pulses; CJC-1295 produces sustained elevation.

Can I take sermorelin orally? No. Sermorelin is a peptide and is degraded by stomach acid. It must be injected subcutaneously or, in rare cases, intranasally (though intranasal bioavailability is poor).

Do I need bloodwork before starting sermorelin? Recommended but not mandatory. Baseline IGF-1 and fasting glucose help establish whether you're a good candidate and provide a comparison point to assess response. Recheck IGF-1 at week 8 to confirm the peptide is working.

Sources

1. Prakash A et al. Growth hormone (GH) response to GH-releasing peptide-2 and sermorelin acetate in healthy elderly men and women. Journal of Clinical Endocrinology & Metabolism. 2003.
2. Walker RF et al. Effects of the synthetic growth hormone-releasing factor (GRF 1-29) on plasma growth hormone, insulin, and glucose levels. Journal of Clinical Endocrinology & Metabolism. 1990.
3. Corpas E et al. Human growth hormone and human aging. Journal of the American Medical Association. 1992.
4. Khorram O et al. Effects of long-term administration of growth hormone-releasing hormone on bone mineral density in elderly men and women. Journal of Clinical Endocrinology & Metabolism. 1997.
5. Sigalos JT et al. Growth hormone secretagogue treatment in hypogonadal men raises serum insulin-like growth factor-1 levels. Therapeutic Advances in Endocrinology and Metabolism. 2018.
6. Jaffe CA et al. Effects of a prolonged growth hormone-releasing hormone infusion on pulsatile growth hormone secretion in normal men. Metabolism. 1998.
7. Wideman L et al. Growth hormone release during acute and chronic aerobic and resistance exercise: recent findings. Sports Medicine. 2005.
8. Lemoine S et al. Effect of growth hormone-releasing peptide-2 infusion on glucose and lipid metabolism in obese adults. Growth Hormone & IGF Research. 2008.
9. Devesa J et al. Hyperglycemic response to growth hormone secretagogues in adults. Endocrine. 2012.
10. Sattler FR. Growth hormone in the aging male. Reviews in Endocrine and Metabolic Disorders. 2015.
11. United States Pharmacopeia. Chapter 797: Pharmaceutical Compounding - Sterile Preparations. 2024.
12. World Anti-Doping Agency. Prohibited List. 2026.
13. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2025.
14. Patel DN et al. Peptide stability in reconstituted solutions: a systematic review. Journal of Pharmaceutical Sciences. 2023.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded sermorelin is not FDA-approved. It is prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Body composition outcomes depend on diet, exercise, adherence, baseline hormone levels, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Geref is a registered trademark of Serono Laboratories. FormBlends is not affiliated with, endorsed by, or sponsored by Serono Laboratories or any other pharmaceutical manufacturer.